LIPO-5

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameLIPO-5
Drug Alias NameHIV-LIPO-5Lipo-5
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunostimulantsHuman immunodeficiency virus gag gene products modulatorsProtein Nef modulators
TargetsProtein NefHuman immunodeficiency virus gag gene products
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofiInserm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A